After a year of living with the pandemic and studying the effects of COVID-19 on adults, we felt the need to shift our focus towards children. Research states that children are less susceptible to SARS-COV-2 infection, have a lower seroprevalence and a less severe form of COVID-19. However, the challenges of COVID-19 diagnoses in children are different from those in adults.
We discussed the implications that come with differential diagnosis, the role that children play in the spread of the infection, presentation of severe cases as well as vaccination and testing with 4 experts from France, Spain, Italy and Israel:
Benoit Vivien: MD, specialist in Anesthesiology and Intensive-Care. Responsible for the regional Pediatric SAMU Ile-de-France and Deputy Head of the Department at SAMU de Paris. He is also a member of the Board of Directors of the French Society for Catastrophe Medicine (SFMC)
Nieves de Lucas: MD, PhD, specialist in Pediatric Intensive Care (PICU) and Master in “Research Methodology: design and statistics in health sciences”. Member of ERC Pediatric Science & Educational Committee, member of 2020-2021 ILCOR and ERC Pediatric guidelines writing group. She currently works at SAMUR-Protección Civil, Madrid, Spain.
Orazio Genovese: MD, PhD, specialist in Pediatrics and PhD in Neurosciences. IRC Instructor for EPALS, BLS e PBLS courses. Professor at Università Cattolica del Sacro Cuore and Intensivist Pediatrician at the PICU of Fondazione Policlinico Universitario A. Gemelli IRCCS, Italy
Ron Berant: MD, Director of the Department of Pediatric Emergency Medicine, at Schneider Children’s Medical Center, in Petach Tikva, Israel.
We've created a topic into our forum with all the articles presented by the speakers: http://www.no-fearproject-portal.eu/forum/38/119
The recordings of the webinar are available here: https://youtu.be/hPIJp--CUQw